BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25990232)

  • 21. Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020-2021.
    Powell LM; Choi SJ; Chipman CE; Grund ME; LaSala PR; Lukomski S
    Emerg Infect Dis; 2023 May; 29(5):898-908. PubMed ID: 37080963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
    Colakoglu S; Alacam R; Hascelik G
    Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.
    Villaseñor-Sierra A; Katahira E; Jaramillo-Valdivia AN; Barajas-García Mde L; Bryant A; Morfín-Otero R; Márquez-Díaz F; Tinoco JC; Sánchez-Corona J; Stevens DL
    Int J Infect Dis; 2012 Mar; 16(3):e178-81. PubMed ID: 22217469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
    Katosova LK; Lazareva AV; Khokhlova TA; Ponomarenko OA; Alyabieva NM
    Antibiot Khimioter; 2016 Aug; 61():23-29. PubMed ID: 29874449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
    Palavecino EL; Riedel I; Berrios X; Bajaksouzian S; Johnson D; Kaplan E; Jacobs MR
    Antimicrob Agents Chemother; 2001 Jan; 45(1):339-41. PubMed ID: 11120993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
    Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
    Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
    Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
    Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological study of erythromycin-resistant Streptococcus pyogenes from Korea and Japan by emm genotyping and multilocus sequence typing.
    Takahashi T; Arai K; Lee DH; Koh EH; Yoshida H; Yano H; Kaku M; Kim S
    Ann Lab Med; 2016 Jan; 36(1):9-14. PubMed ID: 26522753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloned
    Oryaşın E; Bıyık HH; Tristram S; Bozdoğan B
    Microb Drug Resist; 2020 Jul; 26(7):747-751. PubMed ID: 31971866
    [No Abstract]   [Full Text] [Related]  

  • 31. Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001.
    Katz KC; McGeer AJ; Duncan CL; Ashi-Sulaiman A; Willey BM; Sarabia A; McCann J; Pong-Porter S; Rzayev Y; de Azavedo JS; Low DE
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2370-2. PubMed ID: 12821502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and microbiological characteristics of severe infections caused by group A streptococci].
    Hupková H; Zaborská M; Sisovský V; Babál P; Simaljaková M; Koren M; Reis R; Kozáková J
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):164-7. PubMed ID: 25642472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae.
    Megged O; Assous M; Weinberg G; Schlesinger Y
    Isr Med Assoc J; 2013 Jan; 15(1):27-30. PubMed ID: 23484235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain.
    Portillo A; Lantero M; Gastañares MJ; Ruiz-Larrea F; Torres C
    Int J Antimicrob Agents; 1999 Oct; 13(2):137-40. PubMed ID: 10595574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
    Descheemaeker P; Chapelle S; Lammens C; Hauchecorne M; Wijdooghe M; Vandamme P; Ieven M; Goossens H
    J Antimicrob Chemother; 2000 Feb; 45(2):167-73. PubMed ID: 10660498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.
    Perez-Trallero E; Garcia C; Orden B; Marimon JM; Montes M
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):123-6. PubMed ID: 14712367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.
    Yan JJ; Wu HM; Huang AH; Fu HM; Lee CT; Wu JJ
    J Clin Microbiol; 2000 Jul; 38(7):2475-9. PubMed ID: 10878028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.
    Ikebe T; Okuno R; Sasaki M; Kanda Y; Otsuka H; Kawahara R; Ohya H; Suzuki M; Uchida K; Nihonmatsu H; Ohnishi M;
    J Infect Chemother; 2018 Feb; 24(2):117-122. PubMed ID: 29107650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.